Brain-first versus gut-first Parkinsons disease: a hypothesis
Waist circumference: Some providers ask for your waist measurement
Domestic pharmaceutical companies are investing in GLP-1 analog manufacturing, driven by: Rising diabetes and obesity prevalence Government focus on affordable healthcare Established biosimilar capabilities Recent trends include: Early-stage launches of GLP-1 analog generics by Indian manufacturers Increased partnerships between global and Indian firms Expansion of domestic manufacturing capacity These developments will significantly boost local demand for drug delivery devices, particularly low-cost injection systems
LCFAs are ketogenic only under conditions such as starvation and KD (when glucose is low), or diabetes
Last week, leaders of Disability Rights Connecticut, the Disability Rights Project at the Center for Childrens Advocacy, the Connecticut Legal Rights Project, Connecticut Legal Services, and Greater Hartford Legal Aid wrote to Department of Social Services Commissioner Andrea Barton Reeves and other state officials to express their concern in what they call deficiencies and violations of law in the departments proposed rollout of the rule change, which will affect people taking 11 classes of prescription drugs that include over 200 medications
